The price of CVKD is predicted to go up -0.41%, based on the high correlation periods with AWI. The similarity of these two price pattern on the periods is 95.97%.
CVKD
AWI
Down: -0.41%Similarity: 95.97%
CVKD Revenue Forecast
CVKD EPS Forecast
CVKD FAQs
What is bull’s view on CVKD?
CVKD stock has a bullish outlook with a price target of $32, as maintained by HC Wainwright & Co. on November 11, 2024. This represents a significant upside driven by strong buy ratings and potential growth in its therapeutic pipeline. However, recent earnings misses and lack of revenue may pose short-term risks.
What is bear's view on CVKD?
CVKD stock is bearish due to weak fundamentals and recent price volatility. The company missed Q2 2024 EPS estimates (-$0.15 vs. -$0.08) and reported no revenue, reflecting poor financial health. After a recent rally, the stock's +3.89% gain on 2025-01-31 to $19.77 appears unsustainable, with potential downside risk.
What is CVKD eps forecast for next quarter?
The market consensus for CVKD's eps in the upcoming quarter is projected to be approximately $2.15 USD.